get_healthcare_market

tech.dataporium/mcp · Verify this server

Healthcare market data: drug/brand revenue by quarter (brand_revenue, filter symbol), company revenue by healthcare industry, market size by country/region, company market share, industry market size and therapy-area market size. industry values: Pharmaceutical, Medical Device, Diagnostic Life Science, Consumer Healthcare, Health Insurance, Healthcare, Distributor, Veterinary, and others. Drug pipeline (official US government data, updated daily): "drug_approvals": US drug approvals, newest first: original approvals of new drugs (NDA), biologics (BLA) and generics (ANDA), tentative approvals, and new uses (efficacy supplements); novel_drug = first approval of a new active ingredient. Filter by symbol (the listed company that holds the drug today), query (drug or company name), date_from/date_to; filters e.g. {"novel_only": true, "application_type": "NDA,BLA", "approval_kind": "original"}. Also covers vaccines, blood products, allergenics and cell and gene therapies (filters {"center": "CBER", "product_category": "gene therapy"}). Set jurisdiction to another country code (EU, GB, JP, CN, CA, CH, FR, ES, ...) for that country's drug approvals, which have the fields the country publishes (some dates are a year only; see date_precision); more filters: generic, company, year_from, year_to, type, review, kind, form. "drug_approval_summary": counts by group_by (year, month, application_type, category, approval_kind or symbol). "drug_approval_companies": listed companies with their approval and novel drug counts (sort="novel_drugs"). "clinical_trials": registered clinical studies worldwide; filter by symbol (listed lead sponsor), query (words in title, conditions and drugs, e.g. "obesity semaglutide"), phase (early1, 1, 1/2, 2, 2/3, 3, 4, na), status (active, recruiting, completed, stopped, ...), date_from/date_to (start date); filters e.g. {"condition": "Alzheimer", "sponsor": "Mayo Clinic", "country": "Germany", "has_results": true}. "clinical_trial_summary": counts by group_by (phase, status, start_year, study_type, sponsor, symbol, condition or country) with active, recruiting, completed, stopped and phase 3 counts. "clinical_trial": the full record of one study by trial_id (e.g. "NCT04184622"): design, dates, enrollment, eligibility criteria, primary and secondary outcomes and every site. Regulatory pathways (how medicines and devices get approved; reviewed content, each with last_verified and a confidence level; not legal or regulatory advice): "regulatory_markets": the covered markets (codes like US, EU, GB, JP, CN, DE, CA, CH), segments and the shared pathway types. "regulatory_pathways": pathway cards; filter jurisdiction (e.g. "US" or "DE"; EU members include the EU-wide routes) and segment (drug, biologic, biosimilar, generic, otc, vaccine, atmp, combination, device, ivd, samd); filters e.g. {"pathway_type": "conditional", "device_class": "II", "expedited_only": true}. "regulatory_pathway": one pathway by pathway_id (from regulatory_pathways): steps with official day targets and clock stops, requirements, time targets, fees, reliance on other regulators, device classes, approvals per year; where published also scenarios (paths through decision points), the document checklist per step and the after-approval duties (lifecycle). "regulatory_compare": jurisdiction = 2 to 8 codes separated by commas (e.g. "US,EU,JP"), optional segment; routes lined up by pathway type with target days and fees. "regulatory_approvals": approvals from official regulator data across markets (filter jurisdiction, segment, symbol, query, date_from/date_to; filters e.g. {"pathway_type": "biosimilar", "new_active_only": true, "expedited": "conditional"}). "regulatory_approval_stats": counts with group_by (year, jurisdiction, segment, pathway_type, product_class, expedited, therapeutic_area; two with a comma, e.g. "year,pathway_type"). "regulatory_review_times": actual review times per year, only where the official data has both dates. "regulatory_first_approvals": first approval date of a substance in each market (query = substance name). "regulatory_companies": listed companies ranked by approvals (jurisdiction or ALL). "regulatory_fees" and "regulatory_changes": official fees and rule changes or pending reforms. Testing and technical requirements (reviewed, with last_verified and confidence; standards named by code only): "regulatory_technical": the testing each market asks for, by topic (biocompatibility, bench_performance, electrical_safety, emc, software, cybersecurity, usability, sterilization, packaging_shelf_life, risk_management, clinical_investigation, performance_ivd; for medicines stability, analytical_validation, impurities, specifications, bioequivalence, bridging, lot_release, gmp): what must be done, test endpoints, standards, local_test (a test in a local laboratory or sample testing), whether foreign reports are accepted, what the protocol and the report must contain, and the comparison with the US, the EU and other reference markets. Filter jurisdiction (EU members include EU-wide rules), segment, pathway_id (the rows shown on that pathway page), query; filters e.g. {"topic": "biocompatibility", "device_class": "II", "local_test": "required", "standard": "ISO 10993-1", "scope_tag": "implant"}. "regulatory_technical_compare": jurisdiction (one or more codes) against reference markets with difference_type (same, stricter, lighter, extra_local_test, different_edition, not_required, accepts_reference_report, different_approach) and a plain explanation; group_by "topic" or "summary"; filters {"reference": "US,EU", "topic": "...", "difference_type": "extra_local_test"}. "regulatory_standards": standards (ISO, IEC, ICH, national) and which markets recognize, harmonize or adopt them with the edition accepted and the national code; filter jurisdiction, query; filters {"topic": "...", "family": "device", "standard": "ISO 14971"}. The drug pipeline and regulatory answers have website_link: share it with the user.